doi.org/10.18632/oncotarget.210
Original paper

The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?

..., Sareh Parangi
40
Oncotarget
Volume: 1, Issue: 8, Pages: 751 - 756
Published: Dec 31, 2010
Abstract
Received: December 7, 2010 , Accepted: December 31, 2010 , Published: December 31, 2010 // Abstract BRAFV600E is a constitutively active onco-kinase and is the most common genetic alteration in papillary thyroid carcinoma (PTC), and in anaplastic thyroid carcinoma as well, albeit at a lower frequency. The BRAFV600E mutation in some studies has been significantly associated with extra-thyroidal extension, metastases, recurrence, and mortality in...
Paper Fields
Paper Details
Title
The BRAFV600E mutation: what is it really orchestrating in thyroid cancer?
DOI
doi.org/10.18632/oncotarget.210
Published Date
Dec 31, 2010
Journal
Oncotarget
Volume
1
Issue
8
Pages
751 - 756
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.